<%BANNER%>

Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy

PRIVATE ITEM Digitization of this item is currently in progress.

Material Information

Title:
Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
Physical Description:
Mixed Material
Language:
English
Creator:
Nair, Smita K.
Leon, Gabriel De
Boczkowski, David
Schmittling, Robert
Xie, Weihua
Archer, Gerald
Sampson, John H.
Mitchell, Duane A.
Publisher:
BioMed Central (Journal for ImmunoTherapy of Cancer)
Publication Date:

Notes

Abstract:
© 2013 Nair et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
General Note:
doi:10.1186/2051-1426-1-S1-P270 Cite this article as: Nair et al.: Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy. Journal for ImmunoTherapy of Cancer 2013 1 (Suppl 1):P270.
General Note:
Nair et al. Journal for ImmunoTherapy of Cancer 2013, 1(Suppl 1):P270 http://www.immunotherapyofcancer.org/content/1/S1/P270

Record Information

Source Institution:
University of Florida
Holding Location:
University of Florida
Rights Management:
All rights reserved by the source institution.
Resource Identifier:
oclc -
System ID:
AA00019161:00001

Material Information

Title:
Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
Physical Description:
Mixed Material
Language:
English
Creator:
Nair, Smita K.
Leon, Gabriel De
Boczkowski, David
Schmittling, Robert
Xie, Weihua
Archer, Gerald
Sampson, John H.
Mitchell, Duane A.
Publisher:
BioMed Central (Journal for ImmunoTherapy of Cancer)
Publication Date:

Notes

Abstract:
© 2013 Nair et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
General Note:
doi:10.1186/2051-1426-1-S1-P270 Cite this article as: Nair et al.: Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy. Journal for ImmunoTherapy of Cancer 2013 1 (Suppl 1):P270.
General Note:
Nair et al. Journal for ImmunoTherapy of Cancer 2013, 1(Suppl 1):P270 http://www.immunotherapyofcancer.org/content/1/S1/P270

Record Information

Source Institution:
University of Florida
Holding Location:
University of Florida
Rights Management:
All rights reserved by the source institution.
Resource Identifier:
oclc -
System ID:
AA00019161:00001